Lomustine

CAS 13010-47-4 3 current recordsSmall Molecule

Who holds supplier records for Lomustine? 3 organisations hold a current record for Lomustine: an active US FDA Type II Drug Master File or a CEP. 2 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (1); not recorded for 2.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Lomustine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/lomustine

Reading the evidence

  • 3 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 1 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (3)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Lomustine. Country is the organisation's recorded country, not necessarily the manufacturing site.

India1Country not recorded for 2
  • Dr. Reddy's Laboratories Ltd.
    Active DMF 28405 · latest filing Jul 2014
    IndiaCEP Company GMP cert on record
  • STARKS ASSOC INC
    Active DMF 2420 · latest filing Mar 1975
  • UMICORE ARGENTINA SA
    CEP
Need Lomustine sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (2)

Certificates of Suitability on the EDQM register for Lomustine, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

HolderCountryCertificateIssuedEU GMP at holder's address
DR. REDDY'S LABORATORIES LIMITED HyderabadIN
CEP 2009-141 - Rev 04
Lomustine
Feb 2026—
UMICORE ARGENTINA S.A. Buenos AiresAR
CEP 2021-132 - Rev 01
Lomustine
Feb 2026—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (6 listed products contain Lomustine). The latest listed exclusivity ended 19 May 2026. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Lomustine is an alkylating nitrosourea compound that has been used in chemotherapy. It is used primarily for the treatment of brain tumors and Hodgkin's disease.

Chemical identity

IUPAC name
1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea
Canonical SMILES
C1CCC(CC1)NC(=O)N(CCCl)N=O
InChIKey
GQYIWUVLTXOXAJ-UHFFFAOYSA-N
Synonyms
ccn-u, ccnu, ceenu, nsc-79037

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Alkylating Drug
Mechanism of action
Alkylating Activity

Therapeutic areas

Oncology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Lomustine?

3 organisations hold an active US FDA Type II Drug Master File or a CEP for Lomustine: Dr. Reddy's Laboratories Ltd. (India), STARKS ASSOC INC and UMICORE ARGENTINA SA. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Lomustine Drug Master Files are active?

Dr. Reddy's Laboratories Ltd. (DMF 28405) and STARKS ASSOC INC (DMF 2420). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

Does Lomustine have a European Certificate of Suitability?

Yes. 2 organisations hold a valid CEP for Lomustine on the EDQM register, including DR. REDDY'S LABORATORIES LIMITED Hyderabad (IN) and UMICORE ARGENTINA S.A. Buenos Aires (AR). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Lomustine supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Lomustine?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.